contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


elekta-to-highlight-precision-radiation-medicine-solutions-that-improve-patient-outcomes-at-astro-annual-meeting

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Elekta operates in the medical technology industry and focuses on the development, manufacture and distribution of medical equipment for cancer treatment and neurosurgery. The company's products include radiotherapy machines and diagnostic imaging systems. The business has a global market position. Elekta was founded in 1972 and is headquartered in Stockholm.

Elekta

Recent product introductions, including MOSAIQ® Plaza and Elekta Unity MR-Linac, as well as continued advances to the family of HD linear accelerators and MR-guided brachytherapy, demonstrate...

Recent product introductions, including MOSAIQ® Plaza and Elekta Unity MR-Linac, as well as continued advances to the family of HD linear accelerators and MR-guided brachytherapy, demonstrate Elekta's continued commitment to advancing oncology care. Features in the new solutions include higher personalization, improved workflows, better precision and more intelligence through automation as well as through analytics and supporting through evidence-driven decision support."Transforming cancer care is more than just technology innovation - it must address treatment gaps and process inefficiencies that drive up healthcare costs and produce suboptimal patient outcomes," said Richard Hausmann, President and CEO, Elekta. "Healthcare reforms in the USA and elsewhere greatly benefit from Elekta's Precision Radiation Medicine strategy. Our several unique technologies, from Elekta Unity to brachytherapy and Leksell Gamma Knife, enable more hypofractionation possibilities and expand the range of indications."ASTRO attendees are invited to visit Elekta booth 3431 to learn more about how the company is making Precision Radiation Medicine the standard of value-based healthcare with innovative radiation delivery systems and software solutions.For real-time updates from our educational events and the ASTRO show floor, <virtloc>follow @Elekta (https://twitter.com/Elekta)</virtloc>on Twitter. To learn more about Elekta at ASTRO, visit elekta.com/ASTRO (<a href="http://www.elekta.com/ASTRO">http://www.elekta.com/ASTRO</a>).Elekta Unity has CE mark and 510(k) clearance but is not available in all markets. MOSAIQ Plaza is not available in all markets.# # #For further information, please contact: Oskar Bosson, Global EVP Corporate Communications and Investor Relations Tel: +46 70 410 7180, e-mail: <virtloc>Oskar.Bosson@elekta.com</virtloc> Time zone: CET: Central European Time Raven Canzeri, Global Public Relations Manager Tel: +1 770 670 2524, e-mail: <virtloc>raven.canzeri@elekta.com</virtloc> Time zone: ET: Eastern Time About Elekta For almost five decades, Elekta has been a leader in precision radiation medicine. Our nearly 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to - and benefits from - more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com (<a href="http://www.elekta.com/">http://www.elekta.com/</a>) or follow <virtloc>@Elekta (https://twitter.com/Elekta)</virtloc>on Twitter.

Elekta to highlight Precision Radiation Medicine solutions that improve patient outcomes at ASTRO Annual Meeting